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Fluorescent ampicillin analogues as multifunctional
disguising agents against opsonization†
Nalinikanth Kotagiri,‡a,b,c Joshua Sakon,c,d Haewook Han,e,f Vladimir P. Zharovg and
Jin-Woo Kim*a,b,c
Cancer nanomedicines are opening new paradigms in cancer management and recent research points to
how they can vastly improve imaging and therapy through multimodality and multifunctionality. However,
challenges to achieving optimal eﬃcacy are manifold starting from processing materials and evaluating their
intended eﬀectiveness on biological tissue, to developing new strategies aimed at improving transport of
these materials through the biological milieu to the target tissue. Here, we report a ﬂuorescent derivative of
a beta-lactam antibiotic, ampicillin (termed iAmp) and its multifunctional physicobiochemical characteristics
and potential as a biocompatible shielding agent and an eﬀective dispersant. Carbon nanotubes (CNTs)
were chosen to demonstrate the eﬃcacy of iAmp. CNTs are known for their versatility and have been used
extensively for cancer theranostics as photothermal and photoacoustic agents, but have limited solubility in
water and biocompatibility. Traditional dispersants are associated with imaging artifacts and are not fully bio-
compatible. The chemical structure of iAmp is consistent with a deamination product of ampicillin. Although
the four-membered lactam ring is intact, it does not retain the antibiotic properties. The iAmp is an eﬀective
dispersant and simultaneously serves as a ﬂuorescent label for single-walled CNTs (SWNTs) with minimal
photobleaching. The iAmp also enables bioconjugation of SWNTs to bio-ligands such as antibodies through
functional carboxyl groups. Viability tests show that iAmp-coated SWNTs have minimal toxicity. Bio-stability
tests under physiological conditions reveal that iAmp coating not only remains stable in a biologically rele-
vant environment with high protein and salt concentrations, but also renders SWNTs transparent against
nonspeciﬁc protein adsorption, also known as protein corona. Mammalian tissue culture studies with macro-
phages and opsonins validate that iAmp coating aﬀords immunological resistance to SWNTs. Furthermore,
iAmp coating oﬀers protection to SWNTs against their nonspeciﬁc adsorption across disparate cell types,
which has precluded a targeted strategy, and enables selective molecular targeting. The iAmp can therefore
be used as an eﬃcient dispersant, a photostable ﬂuorescent agent, and a biocompatible disguising agent,
alleviating CNTs’ drawbacks and rendering them suitable for nanotheranostic and drug delivery applications.
Introduction
Recent advances in cancer nanomedicine and theranostics
have been greatly facilitated by complementary advances in
materials science and related techniques. Engineered
materials, through their novel properties, have been shown to
enhance cancer detection and treatment outcomes in a multi-
tude of preclinical studies and some have even progressed to
clinical trials.1 Nanoparticulates and related nanosystems
incorporate a multitude of biological and synthetic moieties to
aﬀord superior theranostic capabilities. The multimodality
approach and the modularity of these nanosystems can poten-
tially expand the magnitude and scope of cancer theranostics
to include diverse cancer types and diseases through simple
modulations in synthesis and formulation techniques.
However, translating the advances in material formulation
towards eﬀective cancer nanomedicines has faced significant
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obstacles due to a limited understanding of the interaction of
these engineered materials with the biological environment.
While there have been a plethora of studies showing the eﬀec-
tiveness of novel engineered materials, as a therapeutic or
imaging agent or both,2 determining their dispersity, bio-
compatibility, bio-stability is absolutely vital and inextricably
linked to their eﬀective transport in vivo during translational
eﬀorts. Particularly, the role of the immune system is of para-
mount importance since materials, which are inherently
foreign to the biological environment, are primed for rapid
elimination from the body. Phagocytosis by monocytes and
macrophages dictates the fate of potential theranostic target-
ing platforms in circulation.3 These phagocytes are part of the
innate immune system along with opsonins, i.e., plasma pro-
teins such as complement factors and immunoglobulins,
which attach nonspecifically to foreign objects and tag them
for recognition by macrophages for phagocytosis and seques-
tration to the liver and spleen.4 In addition, nonspecific
adsorption of many other proteins in biological fluids, known
as protein corona, critically aﬀects the interaction of particles
with living systems, plays a decisive role in their biodistribu-
tion and biokinetics, and inevitably controls their in vivo
fate.3,5 Particles that are inert or possess favorable surface pro-
perties will not only escape opsonins and macrophages but
also alleviate the protein corona formation and have a longer
circulation half-life and enhanced biodistribution.3,6,7
Here, we introduce a fluorescent derivative of ampicillin
(termed iAmp), a beta-lactam antibiotic, and its physico-
biochemical characterization. We demonstrate that the iAmp
plays a triple role as a highly eﬀective dispersant, a photostable
fluorescent labeling agent, and a biocompatible disguising
(stealth) agent against innate immune responses as well as
protein corona, to alleviate the drawbacks of nanomaterials
and enables us to realize their full potential for biological and
biomedical applications, particularly nanotheranostics and
drug delivery.
As a proof-of-concept, we selected carbon nanotubes
(CNTs), widely known for their superlative properties and a
challenging material to process for biomedical applications.8
CNTs, particularly singled-walled CNTs (SWNTs), and their
hybrids have shown great potential for cancer theranostics
such as photothermal (PT) therapy, photoacoustic (PA)
imaging, drug delivery, as well as reducing the load of bactere-
mia among many explorative studies.9–24 The challenges
ahead partly stem from unresolved issues such as their poor
biocompatibility, low solubility due to their hydrophobicity,
and dispersibility in biologically relevant physiological
solvents.25–27 One of the most common strategies to render
CNTs biocompatible and dispersible in aqueous solutions is
to use shielding agents such as surfactants, polymers, polysac-
charides, proteins, and DNA.3,18,24,28–30 Among the shielding
agents, the most commonly used are surfactants. However,
surfactant dispersed CNTs are often diﬃcult to handle since
significant flocculation can occur in inadequately optimized
preparations,31 thus compromising imaging and downstream
processes.
Besides improving the solubility and biocompatibility of
CNTs, there are other considerations such as interactions with
body fluids (i.e., human blood, plasma, and serum) and circu-
lation half-life that will be impacted directly by the coating
material. CNTs are known to be recognized by the body’s
immune system and are primed for quick elimination.32 To
realize the potential of CNTs for pharmaceutical and medical
theranostic applications, novel coatings that can render CNTs
transparent to the immune system are required. Traditionally,
polyethylene glycol (PEG) is used to help CNTs evade the
protein corona as well as the mononuclear phagocyte system
(MPS). As noticed in many synthetic materials, there are risks
of an adverse reaction against PEG. Recently, PEG–SWNT
hybrids are not only reported to elicit concentration and
surface density dependent cytotoxicity caused by oxidative
stress,33 but phospholipid–PEG moieties are also shown to be
responsible for complement activation by CNTs, triggering the
lectin pathway.34 Hence, there is a need for alternative shield-
ing strategies that provide not only biocompatibility and solu-
bility in biologically relevant solutions but also a “stealth”
character to CNTs.
Fluorescent ampicillin-like molecules have been syn-
thesized in the past.35 However, complex reaction conditions
were required. Moreover, the chemical structures of these
derivatives were not fully characterized. Our reported tech-
nique is much simpler and cost eﬀective. Several groups have
demonstrated the adsorption of various antibiotics, such as
sulfonamides, quinolones, anthracyclines and beta-lactams,
on CNTs through π–π interaction.36–39 Antibiotic-coated CNTs
were primarily intended for anti-bacterial and anti-cancer
treatment, where CNT served as a transporter of the active
agent. In this study, we have used an inactivated antibiotic,
i.e., iAmp, which has properties distinct from those of the
parent compound, primarily for the structural and functional
enhancement of CNTs. Specifically, we used the iAmp to dis-
perse and render SWNTs biocompatible and fluorescent. We
also demonstrated its utility particularly for nanotheranostics
by showing that the iAmp is able to disguise SWNTs from
opsonins and prevent phagocytosis by macrophages. The work
here thus shows iAmp as a highly biocompatible and versatile
shielding agent, oﬀering much promise for the realization of
nanoparticle-based nanotheranostics and drug delivery.
Experimental section
Materials
All water used was purified and deionized with an EASY pure
RF system (Barnstead, Dubuque, IA; 18.2 MΩ cm). SWNTs
were purchased from Carbon Nanotechnologies Inc. (CNI)
(Houston, TX; CNI Grade/Lot number: P0274). Ampicillin,
ammonia assay kit, complement factor C3b, anti-rabbit
immunoglobulin G (IgG), anti-rabbit IgG conjugated with
fluorescein isothiocyanate (IgG–FITC), and other reagents and
solvents, unless specified, were purchased from Sigma-Aldrich
(Milwaukee, WI), CellTiter 96® AQueous One Solution Cell
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Proliferation Assay from Promega (Madison, WI), 1-ethyl-3-[3-
dimethylaminopropyl]carbodiimide hydrochloride (EDC) and
N-hydroxysulfosuccinimide (Sulfo-NHS) from Pierce Biotech-
nology (Rockford, IL), and Escherichia coli K-12, human macro-
phage, T98G human glioblastoma cell line (CRL-1690™), and
their media from American Type Culture Collection (ATCC)
(Manassas, VA).
Synthesis of iAmp
The iAmp was synthesized by heating a fresh solution of ampi-
cillin consisting of 5 mg of ampicillin and 1 ml of water,
unless specified, in a thermal cycler (Bio-Rad® S-1000™
Thermal Cycler, Bio-Rad Laboratories, Inc., Hercules, CA) for
2 h at 99 °C. To prevent any evaporation, the lid was set to a
temperature of 100 °C. The iAmp solutions were desiccated
using a RapidVap Vacuum Dry Evaporation System (Labconco,
Kansas City, MO).
Dispersion of SWNTs with iAmp
The reaction mixture consisted of 1 mg of pristine SWNTs and
1 ml of water to which 50 μl of iAmp was added. Likewise,
another reaction mixture consisting of 1 mg ml−1 of dispersed
and shortened SWNTs (dsSWNTs) with the same concen-
tration of iAmp was also prepared. The dsSWNTs were syn-
thesized as reported previously.18,24 The reaction mixtures
were subjected to sonication in a bath sonicator (VWR, West
Chester, PA) for 20 min. After sonication, the iAmp–SWNT
adducts were purified from unbound iAmp using a Harvard
Apparatus Ultra-Fast Dialyzer (Holliston, MA) with a cellulose
acetate membrane [2 kDa molecular weight cut-oﬀ (MWCO)]
in water for 24 h at 25 °C.
Antibiotic sensitivity test
Two Luria–Bertani (LB) agar (pH 7; ATCC) plates, one with
50 μg ml−1 of ampicillin and the other with 50 μg ml−1 of
iAmp, were streaked with the E. coli K-12 strain. The plates
were then incubated at 37 °C for 14 h.
Cytotoxicity and bio-stability tests
The cytotoxicity of iAmp and iAmp-coated SWNTs was assessed
by monitoring the cell viability and proliferation for 10 days
using CellTiter 96® AQueous One Solution Cell Proliferation
Assay with a human glioblastoma cell line according to the
specifications by Promega and ATCC. All experiments were per-
formed in compliance with guidelines set by the Institutional
Biosafety Committee (IBC) at the University of Arkansas and
approved by the IBC. Briefly, the cell line was cultured in
Eagle’s Minimum Essential Medium (EMEM) supplemented
with 10% fetal bovine serum at 37 °C and 5% CO2. The incu-
bations of iAmp and iAmp–SWNTs with the cell line were
carried out in 12-well plates, containing the cells seeded for
24 h before applying iAmp or iAmp–SWNTs. Control cells
without iAmp and iAmp–SWNTs or cells treated with iAmp or
iAmp–SWNTs at various concentrations (10–100 μg ml−1 and
100–500 μg ml−1 as final concentrations, respectively) were
incubated for 10 days at 37 °C and 5% CO2. After incubation,
the cell proliferation assay was performed for each sample and
the cell viability profile for each sample was assessed by colori-
metric absorbance at 490 nm using a DU-800 ultraviolet/
visible/NIR (UV/vis/NIR) spectrophotometer (Beckman Coulter
Inc., Fullerton, CA). The extended incubation time of 10 days
was chosen to allow suﬃcient time for the influence, if any, of
iAmp or iAmp–SWNTs on cell viability.
The bio-stability of iAmp–SWNTs was evaluated by testing
whether iAmp–SWNTs remained stable in the biologically rele-
vant environment after incubating them in EMEM with 10%
FBS at 37 °C and 5% CO2 for 10 days. Controls, including
SWNTs only in water and iAmp–SWNTs in 0.1 M PBS buﬀer
(pH 7.4), were also incubated for 10 days at 37 °C and 5% CO2.
After incubation, the samples were purified using the Harvard
Apparatus Ultra-Fast Dialyzer with a 50 kDa MWCO cellulose
acetate membrane in 0.1 M PBS buﬀer (pH 7.4) for 24 h at
25 °C. The bio-stability of the iAmp coating was determined by
assessing the fluorescence intensity of iAmp–SWNTs in each
sample using fluorospectrometry and their dispersity using
Atomic Force Microscopy (AFM) as detailed below. Again, the
10-day extended incubation time was chosen to allow suﬃcient
time for the influence, if any, of the physiological conditions
containing high protein and salt concentrations (e.g., that in
blood) on the stability of iAmp coating.
Ab bioconjugation to iAmp–SWNTs
Carbodiimide chemistry was implemented according to the
manufacturer’s instructions (Pierce Biotechnology, Rockford,
IL) in order to conjugate the carboxyl group at C-22 of the
iAmp on the SWNT hybrid to the amine group on IgG and
IgG–FITC. After the conjugation reaction, excess EDC, Sulfo-
NHS, and free Ab were removed using the Harvard Apparatus
Ultra-Fast Dialyzer with a 300 kDa MWCO cellulose acetate
membrane in 0.1 M PBS buﬀer (pH 7.4) for 24 h at 4 °C.
Interaction of macrophages and opsonins with iAmp–SWNT
hybrids
Human macrophages were purchased from ATCC. All experi-
ments were performed in compliance with the IBC guidelines
and approved by the IBC. Macrophages were cultured accord-
ing to the vendor’s specifications and kept in their original
growth medium (Iscove’s modified Dulbecco’s medium) for
the entirety of the experiments. The iAmp–SWNTs and FITC
tagged iAmp–SWNT–IgG complexes along with the dsSWNT
control were preincubated with opsonins, IgG–FITC and/or
C3b, at 37 °C for 2 h. After incubation, they were added to the
medium containing macrophages and mixed for 2 h at 37 °C.
The samples were then washed (centrifugation at 2200g for
5 min followed by medium exchange) three times to remove
any unbound particles.
Physicochemical characterization
The absorption spectra of samples were obtained using a
DU-800 UV/Vis/NIR spectrophotometer (Beckman Coulter Inc.,
Fullerton, CA) and the fluorescence spectra using a NanoDrop
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3300 Fluorospectrometer (Thermo Fisher Scientific, Inc.,
Wilmington, DE).
Atomic force microscopy (AFM) imaging was carried out
with a Veeco Multimode Scanning Probe Microscope with a
Nanoscope IIIa Controller (Veeco Instruments, Woodbury, NY).
For AFM sample preparation, 25 µl of each sample solution
was mixed with 25 µl of DI water and 5 µl of the mixture was
dispensed on a mica substrate (Novascan, Ames, IA). All
samples were scanned in the tapping mode in air with a Nano-
World Pointprobe® NCSTR AFM probe (NanoWorld AG,
Neuchâtel, Switzerland), which is designed for soft tapping
mode imaging and enables stable and accurate measurements
with a reduced tip–sample interaction, in order to obtain high-
resolution AFM images with minimal sample damage. The
sample scan rate was 1.0 Hz with an aspect ratio of 1 : 1. The
force constant of the tip for scanning was 7.4 N m−1. The free
resonance frequency of the cantilever was automatically tuned
by Nanoscope Software (version v5.31r1; Veeco Instruments).
Phase-contrast and transmittance microscopy were per-
formed using a light microscope (Axioskop 2 Plus, Carl Zeiss,
Inc., Germany) equipped with a 12-bit Color MicroImager II
Cooled digital camera (QImaging, Burnaby, Canada) with a
resolution of 1.3 million pixels. The 100× or 63× oil immersion
objectives (Carl Zeiss) were used to visualize and acquire the
images and their sequences with a digital image and video
recording software, StreamPix (Norpix, Inc., Montreal,
Canada). The light microscopy system was additionally
equipped with two filter sets consisting of band-pass filters
covering 450 to 490 nm (FITC, Carl Zeiss) and 350 to 370 nm
(DAPI, Carl Zeiss) for exciters and absorbance filters covering
wavelengths of 515 nm (FITC, Carl Zeiss) and 400 nm (DAPI,
Carl Zeiss).
Results and discussion
Synthesis and physicobiochemical characterization of iAmp
and its SWNT hybrid
Ampicillin belongs to the penicillin group of beta-lactam anti-
biotics, diﬀering from penicillin G by a single amine group.
The heating of a clear and colorless ampicillin solution to
99 °C resulted in an amber colored iAmp solution (Fig. 1a,
left). The iAmp was highly water-soluble and the compound
did not show any signs of precipitation in water over long time
periods, i.e., ≥6 months. Desiccation left a yellow colored
powder unlike its parent compound, which is white (Fig. 1a,
right). The absolute yield of iAmp as the weight in grams was
very high (>98%) after desiccation, based on mass measure-
ments. The solution emitted intense blue light on irradiation
with UV light (Fig. 1a, middle). The fluorescence quantum
yield (Φ) of iAmp was estimated to be 0.11 (see the ESI†). The
iAmp had a unique absorption and emission maxima at
340 nm and 435 nm, respectively (Fig. 1b), not exhibited by
ampicillin. The iAmp dissolved in water and kept in a clear
container under ambient light conditions for ≥6 months had
a less than 5% loss in its absorbance and fluorescence.
Pure CNTs are highly aggregated, long, and bundled struc-
tures that are held together by weak van der Waals forces. The
iAmp-coated SWNT solution, obtained on sonicating an
admixture of pristine SWNTs with iAmp, acquired a uniform
dark coloration, suggesting that there was a profound increase
in the solubility of SWNTs (Fig. S1 in the ESI†). The iAmp-
coated SWNTs remained photostable and dispersed in water.
The UV/vis absorption spectrum displayed the characteristic
Van Hove peaks of SWNTs, suggesting the separation of
bundles and complete dispersion in an aqueous solvent as
individual tubes (Fig. 2a, red line). This phenomenon was
unique to iAmp and was observed neither for ampicillin
(Fig. 2a, green line) nor for other beta lactam antibiotics such
as amoxycillin and penicillin G (Fig. S1†). AFM was used to
further analyze the high degree of dispersion after purification
of iAmp–SWNT conjugates from unbound iAmp. AFM scans of
pristine SWNTs coated with iAmp showed uniformly dispersed
long SWNTs on the mica surface (Fig. 2b, left). AFM section
analysis revealed the diameter to be 1.2 nm on an average
(Fig. 2c, top). Given the diameter of individual SWNTs is
0.8–1.2 nm, this result confirms that SWNTs were disbanded
completely. In contrast, dispersed and shortened SWNTs
(dsSWNTs) in water (i.e., neither surfactants nor iAmp), pre-
pared through sonication in an acid mixture (H2SO4 +
HNO3),
18,24 did not display the Van Hove peaks; thus, were not
completely unbundled. Conventionally, surfactants such as
triton-X, sodium dodecyl sulfate (SDS), and sodium dodecyl-
benzenesulfonate (NaDBS) are used to fully disperse SWNTs
after such chemical oxidation.29,30,40 However, the surfactant-
coated SWNTs, besides proving cumbersome for high resolu-
tion scanning probe and electron microscopy, can denature
lipids and proteins, thus precluding them from biomedical
studies. Also, surfactants do not confer any additional
traits, which could otherwise potentially expand the range of
Fig. 1 (a) Ampicillin and iAmp solutions in the ambient (left) and UV
(center) lights and their desiccated samples (right). (b) UV/Vis absorption
(green line; left axis) and ﬂuorescence (red line; right axis) spectra of
iAmp solution. RFU indicates relative ﬂuorescence units.
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applications. After treating dsSWNTs in water with iAmp, AFM
scans yielded a similar result as iAmp-treated pristine SWNTs
(Fig. 2b, right), displaying uniformly dispersed SWNTs with a
diameter of 1.2 nm on an average (Fig. 2c, bottom). For the
rest of the study, the iAmp-coated dsSWNT hybrids were used
only because of the relative size uniformity of dsSWNTs as
reported previously.30
To understand the binding mechanism of iAmp to SWNTs,
its structure was elucidated. 1H nuclear magnetic resonance
(NMR) spectroscopy was performed on iAmp dissolved in D2O.
As shown in Fig. S2 in the ESI,† the chemical shifts are labeled
according to the corresponding hydrogen atoms. A comparison
of the 1H NMR spectrum of ampicillin (Fig. S2a in the ESI†)
and that of iAmp (Fig. S2b in the ESI†) highlighted that H-10
was absent in iAmp, while all the other chemical shifts were
invariant. The structure of iAmp must resemble ampicillin
except for H-10. Isoelectric focusing demonstrated that the net
charge of iAmp is negative (Fig. S3 in the ESI†), perhaps due to
the loss of an amine group at C-10. Yet, Fourier transform
infrared (FTIR) spectroscopy performed on dried samples of
iAmp and ampicillin resembled each other (Fig. S4 in the
ESI†). The high-performance liquid chromatography (HPLC)
chromatograms of iAmp showed distinct absorption peaks at
340 nm (Fig. S5 and S6 in the ESI†). Subsequent liquid chrom-
atography-mass spectrometry (LC-MS) yielded the molecular
weight (MW) of iAmp to be 348.8 Da (Fig. S7, top in the ESI†)
and the MW of ampicillin to be 349.7 Da (theoretical mass is
349.4 Da) (Fig. S7, bottom in the ESI†). One less nitrogen atom
in iAmp was assumed based upon the “nitrogen rule”.41
The pH of the ampicillin solution was measured as 7.7 and
that after the formation of iAmp upon heating was 8.75. This
increase in pH could partly be due to the consequence of de-
amination. An ammonium assay was performed to quantitate
ammonia in solution (see the ESI†). Ammonia is measured as
a function of oxidation of nicotinamide adenine dinucleotide
phosphate (NADPH). A decrease in the absorbance of the
sample at 340 nm is an indicator of ammonia in solution.
Upon modifying 5 mg ml−1 of ampicillin to iAmp, 0.27 mg ml−1
of ammonia was produced. The chemical reaction can be
written as:
C16H19N3O4SþH2O !Δ C16H17N2O5Sþ NH3 þHþ þ e
Evidence is consistent with the occurrence of oxidative de-
amination at the C-10 position of ampicillin, resulting in fluo-
rescent iAmp (Fig. 3a). The extended conjugate system of iAmp
not only imparts the unique blue fluorescence but also facili-
tates π–π interaction with SWNTs (Fig. 3b). As reported earlier,
π–π interaction of small molecules with SWNTs is a stable
interaction, preventing desorption from the nanotube surface
in aqueous solutions over prolonged durations.42 Noncovalent
functionalization of small molecules such as pyrene also
resulted only in a partial loss of fluorescence upon binding to
SWNTs, due to charge transfer mechanisms.43 The imaging
and tracking of noncovalently bound pyrene–SWNT conju-
gates, in situ, using fluorescence microscopy was still highly
feasible, notwithstanding the moderate degree of fluorescence
quenching.30,40 Similarly, epi-fluorescence microscopy was
used to evaluate the in situ photostability of iAmp–SWNTs. The
iAmp–SWNTs were visualized at 100× magnification using the
DAPI filter. Bright rod-shaped fluorescent particles were
observed with an exposure time of 250 ms (Fig. 3c) with a
minimal fluorescence quenching. The long fluorescence half-
life could be due to minimal spectral overlap in the emission
spectra of iAmp and absorption spectra of SWNTs. The advan-
tage of using iAmp is that it can disperse SWNTs, in addition
to serving as a fluorescent tag.
Of note is the fact that the iAmp exhibited a marked
decrease in its fluorescence intensity under acidic conditions.
A ∼50% decrease in the intensity at pH = 4.4 was registered
Fig. 2 (a) Vis/NIR absorption spectra of iAmp–SWNTs (red line) and
ampicillin–SWNTs (green line). (b) Phase AFM images of pristine SWNTs
(left) and dsSWNTs (right) with iAmp. Scale bars represent 400 nm (left)
and 200 nm (right). (c) AFM height images (left) and section analysis
plots (right) showing the vertical heights, representatives of the dia-
meters, of iAmp-dispersed pristine SWNTs (top) and dsSWNTs (bottom).
The average diameter is ∼1.2 nm.
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(Fig. 3d). The fluorescence intensity returns to normal on
titrating the pH back to 7.2. A similar behavior was observed
with the iAmp–SWNT complex as well. One can envisage the
use of these complexes as pH sensitive sensors.
Antibiotic activity, cytotoxicity and bio-stability of iAmp and its
SWNT hybrid
Since iAmp has an intact beta-lactam ring, we expected it to
retain the antibiotic activity of ampicillin. Bacterial suscepti-
bility studies using the E. coli K-12 strain, which is sensitive to
ampicillin, were conducted. Two sets of LB agar plates, one
containing iAmp and the other ampicillin, were streaked with
the K-12 strain and grown for 14 h at 37 °C. The plates with
ampicillin showed no growth (Fig. 3e, left) compared to the
normal growth of colonies on the iAmp plates (Fig. 3e, right),
suggesting that iAmp does not possess the antibiotic pro-
perties of its parent compound. It is possible that the uptake
of iAmp by bacteria is reduced due to its structural modifi-
cation. Specifically, the loss of the amino group has the poten-
tial to greatly attenuate its uptake in Gram-negative bacteria
such as E. coli.
Cell viability and proliferation assays revealed no apparent
adverse toxicity eﬀects on live cells after their exposure to
various concentrations of iAmp and iAmp–SWNTs for 10 days
(Fig. 3f and S8 in the ESI†), suggesting that the iAmp coating
improves the biocompatibility of CNTs with minimal cytotoxi-
city. No non-specific association between the mammalian cells
and iAmp–SWNT adducts, after the 10-day incubation period,
was observed, implying that the iAmp coating oﬀers protection
to SWNTs against their nonspecific adsorption across dispa-
rate cell types, therefore enabling selective molecular targeting
by functionalizing the adducts with biomarker specific
ligands.
The bio-stability of iAmp–SWNTs was further tested under
physiological conditions containing high salt and protein con-
centrations found in the blood, by exposing them to PBS and
EMEM with 10% FBS at 37 °C and 5% CO2 for 10 days, respect-
ively. Fluorescence measurements revealed that the fluo-
rescence intensity of iAmp on SWNTs remained stable even
after 10 days of incubation (Fig. S9a–c in the ESI†). Also, AFM
scans yielded a similar result as the control iAmp–SWNTs
(Fig. 2b), displaying uniformly dispersed SWNTs without
noticeable aggregations or association of proteins (Fig. S9d in
the ESI†). This indicates that the iAmp coating, through π–π
interaction with SWNTs, remains stable in such a high protein
and salt environment, which typically displaces surface moi-
eties rapidly from nanoparticles if the associations are weak.
Also, this suggests that the iAmp coating could allow SWNTs
to possess favorable surface properties, alleviating protein
corona formation and enhancing circulation persistence and
biodistribution.
Functionalization of iAmp–SWNT for bio-specificity
The carboxyl group at C-22 (Fig. 3a) can be used for bioconju-
gation reactions. We used carbodiimide chemistry to link the
carboxyl group of iAmp–SWNTs to the amine groups of Ab
using IgG (Fig. 4a). AFM images revealed that the successful
covalent conjugation of Ab resulted in non-uniform ‘beaded’
surface features on SWNTs (Fig. 4b). Section analysis con-
firmed the association through a significant increase in the
diameter (7.1 nm ± 0.69 nm) of the iAmp–SWNT–IgG construct
(Fig. 4c). AFM section analysis of IgG alone showed its average
height of 3.5 nm (±0.93 nm) (Fig. S10 in the ESI†). The
Y-shaped IgG is a flexible molecule with its typical dimensions
of 14.5 nm × 8.5 nm × 4.0 nm.44 The discrepancy in the
Fig. 3 (a) Schematic of ampicillin transforming into iAmp. (b) Schematic
of iAmp π-stacking on SWNT. Note that the schematics do not reﬂect
the actual object sizes. (c) Epi-ﬂuorescence image of iAmp–SWNTs in
PBS. Scale bar represents 500 nm. (d) Fluorescence spectra of iAmp in
an acidic solution of pH 4.4 (red line) and a neutral solution of pH 7.2
(green line). (e) LB agar plates with ampicillin and E. coli K12 (left) and
iAmp and E. coli K12 (right) after 14 h incubation at 37 °C. (f ) Cytotoxicity
studies of iAmp–SWNTs. Note that all experiments were performed
3 times in triplets and the average has been shown as a cell-viability per-
centage in comparison with the iAmp–SWNT untreated control samples
at time 0. The controls at time 0 were considered as 100% viable. The
SWNT, ampicillin, and iAmp models were prepared using Chem3D and
the ChemDraw Pro programs (CambridgeSoft, Cambridge, MA).
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protein size could be explained by the drying induced
reduction in the overall protein dimension during AFM
sample preparations. According to the estimated heights of
IgG (i.e., ∼3.5 nm) and iAmp–SWNTs (i.e., ∼1.2 nm), it is
assumed that the around 6-fold increase in diameter after Ab
conjugation can be attributed to IgG conjugating to SWNTs
(∼2 + 1) along its 3D circumference. During the bioconjugation
reactions, we again noticed that the iAmp–SWNTs remarkably
resisted the nonspecific adsorption of proteins. As seen in
Fig. 4d, when IgG was admixed with iAmp–SWNTs, no associ-
ation between the IgG molecules and iAmp–SWNT adducts
was observed. However, when IgG was admixed with chemi-
cally oxidized SWNTs, i.e., dsSWNTs, without iAmp, dense
aggregations of IgG on the SWNT surface were noticeable
(Fig. 4e). The absence of dense aggregations of protein
moieties on the iAmp–SWNT sidewall reconfirms that nonspecific
hydrophobic interactions are profoundly minimized through
iAmp treatment. We were curious if the iAmp coating could
prevent SWNTs against recognition by cells of the MPS, such
as macrophages, by preventing nonspecific adsorption of
plasma proteins or opsonins.
Macrophage–opsonin model of iAmp–SWNT evasion
Complement factor, C3b, and immunoglobulin, IgG, are the
most abundant opsonins found in human serum with concen-
trations of 0.55 mg ml−1 and 8 mg ml−1, respectively.45 A
single macrophage possesses 2 million receptors for opso-
nins.46 Therefore, in order to achieve a reasonable balance, the
ratio of an opsonin to a macrophage was fixed at 106 : 1. We
assumed that an opsonin/SWNT concentration ratio of 4 : 1
would ensure tagging of all the SWNTs in solution. The IgG
was labeled with a fluorescent dye, fluorescein isothiocyanate
(FITC), to enable the tracking of the dsSWNT control and
iAmp–SWNT complexes in vitro for their interactions with the
opsonin. The particles were preincubated with the opsonins,
IgG–FITC and/or C3b, before introducing them into macro-
phages, to ensure their interactions with the opsonins. The
samples pre-conjugated with IgG and IgG–FITC were also
assessed to confirm the downstream targeting functionality.
Using fluorescence microscopy, the localizations of particles
with respect to macrophages were evaluated. Macrophages
incubated with the control, dsSWNTs, after preincubations
with both IgG–FITC and C3b or IgG–FITC alone, remain highly
fluorescent (Fig. 5a, right). This is indicative of the opsoniza-
tion of dsSWNTs and subsequent internalization by the macro-
phages. Light microscopy revealed a grainy cytoplasm and an
irregular cell membrane (Fig. 5a, left), characteristic signs of
‘loaded’ cells (Fig. 5d, schematic). A similar irregularity was
noticed in macrophages with dsSWNTs after preincubations
with C3b only (Fig. S11 in the ESI†). However, there was no
fluorescence observed in macrophages incubated with iAmp–
SWNTs in the presence of opsonins (Fig. 5b, right) and no irre-
gularity was noticed from macrophages (Fig. 5b, left). Also,
there was no uptake of trypan blue dye by these cells proving
that the cells were viable and the iAmp–SWNT constructs were
nontoxic. Trypan blue is a vital stain used to stain dead cells
blue. Similarly, there was no significant intracellular fluo-
rescence emanating from macrophages when tested with the
IgG–conjugated iAmp–SWNTs, except for the hardly distinct
autofluorescence of cells and backgrounds in the emission/
excitation range of the DAPI filter (Fig. S12 in the ESI†). Fur-
thermore, no fluorescence was observed in macrophages when
Fig. 4 (a) Schematic of the covalent carbodiimide-based coupling of
Ab to iAmp–SWNT. Note that the schematic does not reﬂect the actual
object sizes. (b) Phase AFM image of iAmp–SWNTs after Ab conjugation
(iAmp–SWNTs–IgG). Notice the uneven ‘bumpy’ surfaces of SWNTs in
contrast to iAmp–SWNTs in Fig. 2b, right. Scale bar represents 200 nm.
(c) AFM height image (left) and section analysis plot (right) showing the
diameter of three diﬀerent iAmp–SWNT–IgG constructs in the ﬁeld.
Notice the marked increase in the diameter compared to that of iAmp–
SWNTs in Fig. 2c. The average diameter is ∼7.1 nm. (d) Phase AFM
images of iAmp–SWNT admixed with IgG to observe their non-speciﬁc
interaction. Notice iAmp–SWNT adducts can be identiﬁed as distinctly
separate from the unbound IgG moieties (top). Scale bar represents
500 nm. Magniﬁed phase AFM image clearly demonstrates the absence
of nonspeciﬁc adsorption of IgG on the surface of iAmp–SWNT
(bottom). Scale bar represents 100 nm. (e) Phase AFM images of
dsSWNT admixed with IgG. Notice dense aggregations of IgG on the
SWNT surface (top). Scale bar represents 500 nm. Magniﬁed phase AFM
image shows dense aggregates of IgG on the surface of dsSWNT due to
non-speciﬁc adsorption of IgG on the hydrophobic sidewall of SWNT
(bottom). Scale bar represents 100 nm.
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assessed with iAmp–SWNT–IgG–FITC to avoid any possibility
of masking and attenuation of iAmp fluorescence by the back-
ground autofluorescence (Fig. 5c). These results demonstrate
that iAmp is shielding the SWNTs from opsonins and even-
tually preventing phagocytosis by macrophages (Fig. 5d). This
phenomenon can be mainly attributed to the decrease in van
der Waals and hydrophobic forces on the SWNT surface,
which are primarily implicated in their strong interaction with
cell surfaces. While PEGylation is also known to eﬃciently
shield SWNTs from opsonins, by itself it is not an eﬃcient dis-
persant and does not fluoresce, therefore lacking the versatility
of iAmp.
As reported in our earlier work,24 we hypothesized that
either IgG or C3b could be implicated in exclusively tagging
foreign particles and results in particles being recognized and
phagocytized by macrophages. Based on the results in this
study, we suggest the following. (1) Particles tagged by C3b or
IgG alone can be primed for recognition and internalization
by macrophages. Particularly, since complement receptor
1 (CR1), on the surface of macrophages, does not require C3b
to be in any particular orientation for recognition and binding
purposes, it is important that SWNTs and nanoparticles in
general have an opsonin resistant coating. (2) The reason the
Ab-conjugated iAmp–SWNT was not internalized even though
it was functionalized with IgG, has to do with the orientation
of the IgG on the SWNT surface. Macrophages have receptors
for the Fc region of IgG. No internalization will occur if the
orientation of Ab on the SWNT is such that the Fc region is
inaccessible for binding to the receptors. There is no such
guarantee for the nonspecifically adsorbed Ab as noticed with
the dsSWNT control in the presence of IgG only, suggesting
that careful consideration should be given while designing
probe and targeting systems that use Ab as a homing moiety.
Our site-specific Ab conjugation strategy on the surface of
iAmp–SWNTs did not lead to internalization by macrophages.
We can therefore infer that the majority of the conjugated IgG
were oriented with the Fc region concealed or not conducive
for recognition by macrophages. Also, our Ab functionali-
zation, using tailored surface chemistry through a specific
covalent linkage, enables the Fab region to be favorably
oriented and to retain its binding capacity for molecularly tar-
geted theranostics.
Conclusion
In this study, we have identified a multifunctional fluorescent
derivative of the beta-lactam antibiotic ampicillin, i.e., iAmp,
which has significant implications for improving the in vivo
eﬀectiveness of theranostic materials. It was easy to synthesize,
through a one-step procedure, and to process for coating nano-
particles, such as SWNTs. It imparted several of its unique
traits such as solubility, bio-stability, fluorescence, pH sensi-
tivity, inert structure, and biocompatibility to SWNTs, which
are very important for translation into biological and bio-
medical practices. The high fluorescence quantum yield along
with its stability against precipitation and photobleaching
under ambient conditions could qualify the iAmp as a fluoro-
phore for several applications. Its fluorescence was quenched
in an acidic environment but recovered completely under
neutral and basic conditions. The antibacterial properties of
its parent compound were attenuated and viability tests
showed that iAmp has minimal toxicity. The structure
resembled that of ampicillin except for the amine group at
H-10 replaced by a carbonyl group. The iAmp improved the
solubility and assisted the uniform dispersion of SWNTs as
shown through characteristic Van Hove peaks in absorbance
readings and AFM analyses. Its coating through π–π interaction
Fig. 5 Light (left) and epi-ﬂuorescence (right) microscopy images of
macrophages with: uncoated dsSWNTs (a), iAmp–SWNTs (b), and iAmp–
SWNT–IgG–FITC (c). Uncoated dsSWNTs and iAmp–SWNT hybrids were
preincubated with opsonins, i.e., C3b and/or IgG–FITC. Scale bar rep-
resents 25 μm. (d) Schematic illustrating stealth characters aﬀorded by
coating SWNTs with iAmp. Macrophages recognize uncoated dsSWNTs
tagged by C3b and/or IgG through CR1 and Fc receptors, respectively.
Subsequently, macrophages phagocytize the opsonized SWNTs.
However, iAmp is shielding the SWNTs from opsonins, preventing
phagocytosis by macrophages. Also, the majority of the conjugated IgG
to iAmp–SWNTs are oriented with the Fc region concealed, alleviating
recognition by macrophages. Note that the schematics do not reﬂect
the actual object sizes.
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drastically improved the biocompatibility of SWNTs with
minimal cytotoxicity, remained stable under biologically rele-
vant conditions with high protein and salt concentrations, and
rendered SWNTs notable resistances against nonspecific
adsorptions of proteins and cells. The iAmp–SWNT adducts
were visualized through epi-fluorescence microscopy, which
makes it feasible to track SWNTs in situ and perform real time
diﬀusion based studies in physiological solutions. A site-
specific bioconjugation of Ab could be achieved through tai-
lored surface chemistry, facilitating highly specific target
binding. The macrophage–opsonin model revealed that the
iAmp coating aﬀorded stealth characters to SWNTs and eﬀec-
tively prevented nonspecific adsorption of opsonins, IgG and/
or C3b, and phagocytosis by macrophages. This suggests a
potential long circulation time of iAmp–SWNTs in vivo with
transparency against nonspecific protein and cell adsorptions.
Hence, although further validation is required in in vivo
animal models, which are currently underway, iAmp has
shown high promise to facilitate cancer nanotheranostics as it
would not only improve the circulation half-life and biodistri-
bution of nanomaterials but also impart useful traits to the
material for treating and imaging cancer.
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